Prediction of respiratory distress syndrome using the Abbott FLM-II amniotic fluid assay

Clinica Chimica Acta

Volumn 326, Issue 1-2, 2002, Pages 61-68

  Kaplan, Lawrence A ^a   Chapman, John F ^b   Bock, Jay L ^c   Maria, Edward Santa ^c   Clejan, Sanda ^d   Huddleston, David J ^e   Reed, Roberta G ^f   Bernstein, Larry H ^g   Gillen Goldstein, Jonathan ^h  

^a BELLEVUE HOSPITAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e St Marys Hospital Decatur   (United States)

^f BASSETT MEDICAL CENTER   (United States)

^g BRIDGEPORT HOSPITAL   (United States)

^h NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fetal lung maturity; Premature gestational age; Risk models; Surfactant

Indexed keywords

ALBUMIN; LUNG SURFACTANT; ALBUMINOID;

AMNION FLUID ANALYSIS; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DIAGNOSTIC TEST; GESTATIONAL AGE; HUMAN; INFANT; MEDICAL RECORD; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; RESPIRATORY DISTRESS SYNDROME; REVIEW; AMNION FLUID; CHEMISTRY; FEMALE; FETUS MATURITY; LUNG; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NOTE; PREDICTION AND FORECASTING; PREGNANCY; PRENATAL DEVELOPMENT;

ALBUMINS; AMNIOTIC FLUID; FEMALE; FETAL ORGAN MATURITY; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; LUNG; PREDICTIVE VALUE OF TESTS; PREGNANCY; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 0036890286     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00336-4     Document Type: Review

References (14)

1. Chapman J.F., Tsongalis G.J. Pregnancy and fetal development. Kaplan L.A., Pesce A.J. Clinical chemistry: theory, analysis, correlation. 3rd ed. 1996;808-811 CV Mosby, St. Louis, MO.
2. College of American Pathologists' Proficiency Survey. Lung maturity (set LM-A), 2000.
3. Standards of laboratory practice: guidelines for the evaluation and management of the newborn. National Academy of Clinical Biochemistry, 1998.
4. Fishman A.P. Pulmonary diseases and disorders. 2nd ed. 1998;2251-2254 McGraw-Hill, New York.
5. Vermunt J.K., Magidson J. Latent class cluster analysis. Hagenaars J.A., McCutcheon A.L. Advanced latent class analysis. 2000;1-21 Cambridge Univ. Press, Cambridge.
6. Magidson J. Maximum likelihood assessment of clinical trials based on an ordered categorical response. Drug Inf. J. 30:1996;143-170.
7. Magidson J. Introducing a new graphical model for the analysis of an ordered categorical response: Part I. J. Target. Meas. Anal. Mark. 4:1995;133-148.
8. Goodman L.A. The analysis of dependence in cross-classification having ordered categories, using log-linear models for frequencies and log-linear models for odds. Biometrics. 39:1983;149-160.
9. Berman S., Tanasijevic M.J., Alvarez J.G., Ludmir J., Lieberman E., Richardson D.K. Racial differences in the predictive value of the TDx fetal lung maturity assay. Am. J. Obstet. Gynecol. 175:1996;73-77.
10. Rohlfs E.M., Chaing S.H., Chapman J.F. Analytical and clinical evaluation of refractive index-matched anomalous diffraction (RIMAD) for assessment of fetal lung maturation. Clin. Chem. 42:1996;1861-1868.
11. Tanasijevic M.J., Winkelman J.W., Wybenga D.R., Richardson D.K., Greene M.F. Prediction of fetal lung maturity in infants of diabetic mothers using the FLM S/A and disaturated phosphatidylcholine tests. Am. J. Clin. Pathol. 105:1996;17-22.
12. Fantz C.R., Powell C., Karon B., Parvin C.A., Hankins K., Dayal M.et al. Assessment of the diagnostic accuracy of the TDx-FLM II to predict fetal lung maturity. Clin. Chem. 48:2002;761-765.
13. Tanasijevic M.J., Wybenga D.R., Richardson D., Greene M.F., Lopez R., Winkelman J.W. A predictive model for fetal lung maturity employing gestational age and test results. Am. J. Clin. Pathol. 102:1994;788-793.
14. Bernstein L.H., Qamar A., McPherson C., Zarich S. Evaluating a new graphical ordinal logit method (GOLDminer) in the diagnosis of myocardial infarction utilizing clinical features and laboratory data. Yale J. Biol. Med. 72:1999;259-268.